Andaman7 argues case for greater patient mediated research at HIMSS European Health Conference 2022
Vincent Keunen, CEO and Founder of Andaman7, to share best practice for implementing a patient-centered approach to effectively engage people in the transformation of digital health
Liege, Belgium – 14 June, 2022: ‘Data undoubtedly is the golden thread within healthcare, but the challenge lies in promoting willingness to both share, and use health data for primary and secondary use.’ That is the argument for a key session at the 2022 HIMSS European Health Conference, where Vincent Keunen, CEO and Founder of Belgian-American digital health company Andaman7, will participate with other HIMSS Digital Influencers and thought leaders to focus on ‘acceptance, adoption and attitudes towards data sharing, including discussion of the various sources of health data and interoperability, touching on implemented strategies for building trust across all stakeholders; citizens, clinicians, patients and researchers.’
The European conference is part of a wide-ranging response to mitigate the economic and social impact of the coronavirus pandemic, with the EU investing €673bn in “recovery and resilience,” of which at least €13bn targets investment in digital health transformation. Building back stronger and more resilient health systems is the key objective for national digital transformation programs, requiring healthcare and IT leaders to look at greater collaboration across the ecosystem.
Commenting on his participation, Vincent Keunen says:
“Having experience as both a cancer patient and digital health solutions provider, I understand first-hand what is needed, both to shape the future of technology and to improve access to care for patients.
“Disruptive developments such as telemedicine, remote patient monitoring, and interoperability of patient electronic records is shifting power and accountability for healthcare into patients’ hands. Patient mediated research is the next stage - from automated Patient Reported Outcomes (PROs), through Hospital and Patient Health Records (PHR), to Medication Adherence Data for both prescribed and over the counter (OTC) drugs. This additional focus on the use of Real-world data (RWD) and real-world evidence (RWE) will play an increasing role in health care and regulatory decision making, including approval of new indications for approved drugs.”
The session, entitledBuilding and Maintaining Trust in the use of Health Data will take place Thursday 16 June, 2022 from 10:45-11:45 am LOCAL TIME Helsinki.
The 2022 HIMSS European Health Conference & Exhibition in Helsinki, Finland, from 14 to 16 June 2022 will cover themes including digital transformation, cybersecurity, interoperability, and data into knowledge.
For more information visit: https://www.himss.org/event-himss-europe
- END –